These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 37801268)
1. The effect Of vascular related CeRNA genes and corresponding imaging biomarkers on survival in lower grade glioma. Guo Y; Guo H; Tong H; Xue W; Xie T; Wang L; Tong H Ir J Med Sci; 2024 Apr; 193(2):653-663. PubMed ID: 37801268 [TBL] [Abstract][Full Text] [Related]
2. Construction of ceRNA networks with different types of Wang WJ; Lu YJ; Li Y; Tang JQ; Wang H; Song W; Wang JJ; Huang YQ; Wang Y; Lian L Ann Transl Med; 2022 Mar; 10(5):254. PubMed ID: 35402587 [TBL] [Abstract][Full Text] [Related]
3. Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma. Li X; Zhang J; Zhang M; Qi X; Wang S; Teng J Medicine (Baltimore); 2021 Oct; 100(39):e27248. PubMed ID: 34596120 [TBL] [Abstract][Full Text] [Related]
4. Identification of potential biomarkers related to glioma survival by gene expression profile analysis. Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197 [TBL] [Abstract][Full Text] [Related]
5. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924 [TBL] [Abstract][Full Text] [Related]
6. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis. Qi C; Lei L; Hu J; Wang G; Liu J; Ou S J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801 [TBL] [Abstract][Full Text] [Related]
7. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data. Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666 [TBL] [Abstract][Full Text] [Related]
8. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma. Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355 [TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma. Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479 [TBL] [Abstract][Full Text] [Related]
10. Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma. Su X; Li H; Chen S; Qin C Technol Cancer Res Treat; 2021; 20():15330338211010143. PubMed ID: 33896271 [TBL] [Abstract][Full Text] [Related]
11. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma. Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420 [TBL] [Abstract][Full Text] [Related]
12. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas. Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009 [TBL] [Abstract][Full Text] [Related]
13. Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures. Wang Y; Wang Z; Zhao B; Chen W; Wang Y; Ma W Cancer Med; 2020 Dec; 9(24):9266-9281. PubMed ID: 33047900 [TBL] [Abstract][Full Text] [Related]
14. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy. Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X Front Immunol; 2022; 13():899710. PubMed ID: 35677036 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Transcriptomic Analysis and Experimental Validation Identify lncRNA HOXA-AS2/miR-184/COL6A2 as the Critical ceRNA Regulation Involved in Low-Grade Glioma Recurrence. Chen PY; Li XD; Ma WN; Li H; Li MM; Yang XY; Li SY Onco Targets Ther; 2020; 13():4999-5016. PubMed ID: 32581558 [TBL] [Abstract][Full Text] [Related]
16. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma. Hao YP; Wang WY; Qiao Q; Li G Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884 [TBL] [Abstract][Full Text] [Related]
17. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis. Yang A; Wang X; Hu Y; Shang C; Hong Y Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971 [TBL] [Abstract][Full Text] [Related]
18. The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data. Zhang B; Wu Q; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Wang Z; Zhou YL J Cell Biochem; 2019 Sep; 120(9):15106-15118. PubMed ID: 31020692 [TBL] [Abstract][Full Text] [Related]
19. A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma. Liu W; Zou J; Ren R; Liu J; Zhang G; Wang M Technol Cancer Res Treat; 2021; 20():1533033821992084. PubMed ID: 33550903 [TBL] [Abstract][Full Text] [Related]
20. 3D-ASL perfusion correlates with VEGF expression and overall survival in glioma patients: Comparison of quantitative perfusion and pathology on accurate spatial location-matched basis. Pang H; Dang X; Ren Y; Zhuang D; Qiu T; Chen H; Zhang J; Ma N; Li G; Zhang J; Wu J; Feng X J Magn Reson Imaging; 2019 Jul; 50(1):209-220. PubMed ID: 30652410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]